- Ustekinumab in treating psoriatic arthritis +12015 | First Faculty of Medicine
- Ustekinumab - indications in the treatment of Crohn's disease2018 | First Faculty of Medicine
- Efficacy of ustekinumab in a patient refractory to other biological treatment2018 | First Faculty of Medicine
- Ustekinumab in management of psoriatic arthritis with severe plaque skin involvement a case report2014 | Publication without faculty affiliation
- Inhibition of interleukins 12 and 23 - experience of plaque psoriasis therapy by ustekinumab2013 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Dermatitis herpetiformis Duhring in a patient suffering from psoriasis treated with ustekinumab2016 | Third Faculty of Medicine
- Ustekinumab in systemic treatment of psoriasis2009 | First Faculty of Medicine
- Modulation of IL-12/IL-23 signaling pathways by ustekinumab alleviates inflammation in Crohn's disease patients2018 | Faculty of Medicine in Hradec Králové
- Safety of vedolizumab and ustekinumab in the treatment of pregnant women with inflammatory bowel disease - a multicentre retrospective-prospective observational study2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Our Experience with Ustekinumab for the Treatment of Psoriasis2011 | Second Faculty of Medicine
- Risankizumab vs. ustekinumab for plaque psoriasis: a critical appraisal2019 | Faculty of Medicine in Pilsen
- Severe psoriasis treated with ustekinumab2013 | Third Faculty of Medicine
- Psoriasis therapy in 2011: Commneted review of American a German guidelines news focused on ustekinumab2011 | First Faculty of Medicine
- Selective access to the therapy of plaque psoriasis: a report on meeting in Vinna, 26.-27. Nov 20092010 | Faculty of Medicine in Hradec Králové
- New knowledge in psoriasis etiopathogenesis; protein p40 blocade2010 | Faculty of Medicine in Hradec Králové
- Inhibition of interleukins 12 and 23- novel therapy for plaque psoriasis2010 | Faculty of Medicine in Hradec Králové
- Ustekinutab in the treatment of psoriasis2017 | Publication without faculty affiliation
- Perspectives of biological therapy on inflammatory bowel disease2014 | First Faculty of Medicine
- Differences in the placental pharmacokinetics of vedolizumab and ustekinumab during pregnancy in women with inflammatory bowel disease: a prospective multicentre study2021 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Complicated course of IBD in pregnancy2023 | First Faculty of Medicine, Central Library of Charles University
- Vedolizumab vs. Ustekinumab as second-line therapy in Crohn's disease in clinical practice2019 | First Faculty of Medicine
- Safety of Ustekinumab and Vedolizumab During Pregnancy-Pregnancy, Neonatal, and Infant Outcome: A Prospective Multicentre Study2022 | Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine, Central Library of Charles University
- Těžká forma psoriázy a psoriatické artritidy léčená ustekinumabem - kazuistika2012 | Third Faculty of Medicine
- Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study2022 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
- Long-term combination therapy of ustekinumab and dapsone in a patient with psoriasis and dermatitis herpetiformis Duhring2012 | Third Faculty of Medicine
- Inhibition of IL-17 - a new approach in the biological treatment of spondyloarthritides2017 | First Faculty of Medicine
- Safety and Potential Efficacy of Escalating Dose of Ustekinumab in Pediatric Crohn's Disease (the SPEED-UP study) - A Multicenter Study from the Pediatric IBD Porto Group of ESPGHAN2022 | Second Faculty of Medicine
- Biologic treatment of chronic severe psoriasis2012 | Faculty of Medicine in Pilsen, First Faculty of Medicine
- Temporal arteritis - pitfalls in diagnosis and treatment2019 | First Faculty of Medicine
